I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Eberlein, Cath
24
results:
Search for persons
X
Format
Online (24)
Mediatypes
Articles (Online) (12)
OpenAccess-fulltext (12)
Sorted by: Year
Sorted by: Relevance
?
1
Capivasertib combines with docetaxel to enhance anti-tumour..:
Eberlein, Cath
;
Williamson, Stuart C.
;
Hopcroft, Lorna
...
British Journal of Cancer. 130 (2024) 8 - p. 1377-1387 , 2024
Link:
https://doi.org/10.1038/..
?
2
Combining the AKT inhibitor capivasertib and SERD fulvestra..:
Hopcroft, Lorna
;
Wigmore, Eleanor M.
;
Williamson, Stuart C.
...
npj Breast Cancer. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
3
Author Correction: Combining the AKT inhibitor capivasertib..:
Hopcroft, Lorna
;
Wigmore, Eleanor M.
;
Williamson, Stuart C.
...
npj Breast Cancer. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
4
Pharmacokinetics of the Akt Serine/Threonine Protein Kinase..:
Miller, Claire
;
Sommavilla, Roberto
;
Barry, Simon T.
...
Clinical Pharmacology in Drug Development. 12 (2023) 9 - p. 856-862 , 2023
Link:
https://doi.org/10.1002/..
?
5
Author Correction: Combining the AKT inhibitor capivasertib..:
Hopcroft, Lorna
;
Wigmore, Eleanor M.
;
Williamson, Stuart C.
...
npj Breast Cancer. 9 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
6
Author Correction: Combining the AKT inhibitor capivasertib..:
Lorna Hopcroft
;
Eleanor M. Wigmore
;
Stuart C. Williamson
...
https://doi.org/10.1038/s41523-023-00575-6. , 2023
Link:
https://doi.org/10.1038/..
?
7
Combining the AKT inhibitor capivasertib and SERD fulvestra..:
Hopcroft, Lorna
;
Wigmore, Eleanor M
;
Williamson, Stuart C
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404292/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
8
Author Correction: Combining the AKT inhibitor capivasertib..:
Lorna Hopcroft
;
Eleanor M. Wigmore
;
Stuart C. Williamson
...
https://doi.org/10.1038/s41523-023-00581-8. , 2023
Link:
https://doi.org/10.1038/..
?
9
Author Correction: Combining the AKT inhibitor capivasertib..:
Hopcroft, Lorna
;
Wigmore, Eleanor M
;
Williamson, Stuart C
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439172/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
10
Combining the AKT inhibitor capivasertib and SERD fulvestra..:
Lorna Hopcroft
;
Eleanor M. Wigmore
;
Stuart C. Williamson
...
https://doi.org/10.1038/s41523-023-00571-w. , 2023
Link:
https://doi.org/10.1038/..
?
11
Author Correction: Combining the AKT inhibitor capivasertib..:
Hopcroft, Lorna
;
Wigmore, Eleanor M
;
Williamson, Stuart C
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509253/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
AKT-mTORC1 reactivation is the dominant resistance driver f..:
Dunn, Shanade
;
Eberlein, Cath
;
Yu, Jason
...
Oncogene. 41 (2022) 46 - p. 5046-5060 , 2022
Link:
https://doi.org/10.1038/..
?
13
AKT-mTORC1 reactivation is the dominant resistance driver f..:
Dunn, Shanade
;
Eberlein, Cath
;
Yu, Jason
...
Oncogene;41. , 2022
Link:
https://hdl.handle.net/1..
?
14
AKT-mTORC1 reactivation is the dominant resistance driver f..:
Dunn, Shanade
;
Eberlein, Cath
;
Yu, Jason
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652152/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
15
Mixed micelles of lipoic acid-chitosan-poly(ethylene glycol..:
Elsaid, Zeeneh
;
Taylor, Kevin M.G.
;
Puri, Sanyogitta
...
European Journal of Pharmaceutical Sciences. 101 (2017) - p. 228-242 , 2017
Link:
https://doi.org/10.1016/..
1-15
